ABVC BioPharma, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 168.8% | 168.8% | -6,206.8% |
| FY2017 | 241.5% | 241.5% | -160.5% |
| FY2018 | 107.2% | 107.2% | -102.1% |
| FY2019 | 2,605.4% | 2,605.4% | -56.8% |
| FY2020 | -308.1% | -308.1% | -91.3% |
| FY2021 | -145.2% | -145.2% | -93.7% |
| FY2022 | -530.0% | -530.0% | -171.4% |
| FY2023 | -501.1% | -501.1% | -100.0% |
| FY2024 | -399.9% | -399.9% | -65.0% |
| FY2025 | -71.2% | -71.2% | -37.5% |